Valuation: Beijing Science Sun Pharmaceutical Co., Ltd.

Market Cap 4.54B 671M 588M 543M 500M 942M 64.62B 962M 6.49B 2.55B 31.71B 2.52B 2.46B 109B P/E 2024
-50.1x
P/E 2025 353x
Enterprise Value 3B 443M 388M 358M 330M 622M 42.68B 635M 4.28B 1.68B 20.94B 1.66B 1.63B 71.97B EV / Sales 2024
4.33x
EV / Sales 2025 8.78x
Free-Float
42.82%
Yield 2024 *
-
Yield 2025 2.84%
1 day-9.76%
1 week-3.08%
Current month-0.84%
1 month+15.71%
3 months-20.96%
6 months-16.47%
Current year-10.87%
1 week 9.31
Extreme 9.31
10.51
1 month 7.77
Extreme 7.77
10.66
Current year 7.77
Extreme 7.77
12.9
1 year 7.77
Extreme 7.77
17.49
3 years 5.73
Extreme 5.73
17.49
5 years 5.73
Extreme 5.73
18.75
10 years 5.73
Extreme 5.73
28.08
Manager TitleAgeSince
Chief Executive Officer 62 2001-07-04
Director of Finance/CFO 45 2024-01-25
Director of Finance/CFO 57 2006-12-14
Director TitleAgeSince
Director/Board Member 53 2024-01-25
Director/Board Member 48 2009-02-28
Chairman 62 2001-07-04
Date Insider Type Main position Quantity % Market Cap.
1/20/26 Sell

Director

780,000 0.3078%
1/15/26 Sell

Director

2,301,800 0.9083%
1/14/26 Sell

Director

2,445,200 0.9649%
Change 5-day change 1-year change 3-year change Capi.($)
-9.76%-3.08%-31.27%-7.46% 670M
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -1.04%+0.24%+22.19%+49.50% 357.57B
Weighted average by Cap. +0.37%+0.02%+37.74%+81.48%

Financials

2024 2025
Net sales 416M 61.54M 53.9M 49.75M 45.82M 86.41M 5.93B 88.17M 595M 234M 2.91B 231M 226M 9.99B 405M 59.8M 52.38M 48.34M 44.53M 83.97M 5.76B 85.68M 578M 227M 2.83B 225M 220M 9.71B
Net income -68.85M -10.17M -8.91M -8.22M -7.58M -14.29M -980M -14.58M -98.32M -38.62M -481M -38.21M -37.36M -1.65B 14.57M 2.15M 1.89M 1.74M 1.6M 3.02M 207M 3.08M 20.81M 8.17M 102M 8.09M 7.91M 350M
Net Debt -1.57B -232M -203M -188M -173M -326M -22.36B -333M -2.24B -882M -10.97B -872M -853M -37.7B -1.54B -228M -200M -184M -170M -320M -21.94B -326M -2.2B -865M -10.77B -856M -837M -37B
Logo Beijing Science Sun Pharmaceutical Co., Ltd.
Beijing Science Sun Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of injectables. The Company's products are biological and biochemical drugs, covering several drug use areas: cardiovascular and cerebrovascular diseases, immune diseases (anti-tumor) and nervous system diseases. The main products of immunomodulatory drugs are Saisheng Bozhi glycopeptide injection and Saisheng deoxyribonucleotide sodium injection. The main products of cardiovascular and cerebrovascular drugs are Saibai fibrinolytic enzyme injection, myo-aminopeptide injection and myo-aminopeptide injection. The main product of nervous system drugs is Saidian monosialotetrahexosylganglioside sodium injection (GM-1). The Company mainly conducts its businesses in the domestic market.
Employees
489
Date Price Change Volume
26-07-17 CN¥9.430 -9.76% 22,928,200
26-07-16 CN¥10.45 +3.47% 25,196,950
26-07-15 CN¥10.10 +3.06% 25,979,844
26-07-14 CN¥9.800 +1.34% 13,363,100
26-07-13 CN¥9.670 -0.62% 17,073,500
  1. Stock Market
  2. Stocks
  3. 300485 Stock